The oral medication Vumerity (diroximel fumarate) has been approved by the European Commission to treat adults with relapsing-remitting…
Articles by Marisa Wexler, MS
Measuring levels of the protein serum neurofilament light chain (NfL)Â can help to identify people with relapsing-remitting multiple sclerosis (RRMS)…
The multiple sclerosis (MS) treatment Tecfidera (dimethyl fumarate) triggers immune cell death by interacting with a protein called…
Ocrevus (ocrelizumab) continues to be the most commonly prescribed therapy for progressive forms of multiple sclerosis (MS), including…
Among people with nervous system damage indicative of multiple sclerosis (MS), but who don’t yet have the disease —…
Not drinking alcohol significantly increases the risk of developing multiple sclerosis (MS), especially if a person also is a…
This year’s Women Against Multiple Sclerosis (WAMS) Gala, which aims to raise funds for multiple sclerosis (MS) research, will…
People who contract infectious mononucleosis — colloquially known as “mono” — during childhood or adolescence are at a roughly two…
Colder ambient temperatures may ease the inflammation that drives multiple sclerosis (MS), early research in a mouse model suggests.
Black and Hispanic/Latinx people with multiple sclerosis (MS) in the U.S. tend to have more severe disease, but less…
Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee…
Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European…
Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee…
Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European…
Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European…
Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European…
Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European…
Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European…
Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European…
Treatment with hydroxychloroquine, an anti-malaria medication, appeared to help slow disability progression among people with primary-progressive multiple sclerosis (PPMS)…
Treatment with evobrutinib, an experimental therapy for relapsing forms of multiple sclerosis (MS), reduced the size of inflammation-associated brain…
Increasing the activity of a gene called Myc can make oligodendrocyte precursor cells, or the cells that repair myelin, more…
An upcoming conference focused on progressive multiple sclerosis (MS) will offer the latest insights about the underlying biology of…
Cognitive rehabilitation is an effective therapy for cognitive problems brought on by multiple sclerosis (MS), a review study highlights.
The therapeutic administration of mesenchymal stem cells can improve functional abilities and promote the restoration of lost myelin in rodent…
In an unexpected discovery, scientists working to understand the biological underpinnings of brain tumors found that increasing the activity of…
The presence of a light-sensing protein in the brain during the early stages of fetal development may help to explain…
First-line treatment with Tecfidera (dimethyl fumarate) leads to a lower rate of relapses in people with relapsing-remitting multiple…
People who develop colon cancer are more likely to die in the first year, from that cancer or other causes,…
Anti-CD20 antibody therapies that target B-cells are highly effective for reducing the risk of relapses in people with relapsing-remitting…